BALPHARMA has declared results for the period ended Mar 2021.
Quarterly Results
[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]
- Sales for period ended Mar 2021 is Rs 70.29 cr compared to Rs 33.77 cr for period ended Mar 2020, a rise of 108.1%
- Operating Profits reported at Rs 6.96 cr for period ended Mar 2021 vis-vis 1.28 for period ended Mar 2020 .
- Operating Margins expanded 611.1 bps for period ended Mar 2021 vis-vis Mar 2020 .
- The EPS for Mar 2021 was Rs 2.95 compared to Rs 1.09 for previous quarter ended Dec 2020 and Rs -2.48 for Mar 2020
- The stock is trading at Rs 97.10 and a market cap of Rs 144 cr
[/s2If]
Trading Chart
Further analysis and Full Company Research with investing scores is available here: BALPHARMA